Welcome to Washington D. C. and BIT’s 2nd Annual International Congress of Biotherapy (ICB-2018) & BIT’s 10th Anniversary of International Congress of Antibody (ICA-2018) & BIT’s 11th Anniversary of World Congress of Vaccines (WCV-2018). We are honored to announce that the influential antibody event will be held during March 23-25, 2018 in Washington D. C., USA. With the theme of “The Fourth Revolutionary Wave of Pharm Industry”, the congress will provide an opportunity to bring together professional representatives all over the world.

This conference will be an outstanding experience, both scientifically and socially. ICB-2018 & ICA-2018 & WCV-2018 aims to be the most comprehensive antibody congress where discoveries meet opportunities. During 9 years of successful running of ICA, it has attracted more than 3,700 participants from 60 countries. We are trying our best to be the unique platform for Academic & Industrial information exchange & network expansion. The congress venue Washington D. C. is USA's largest economic comprehensive industrial base, and a famous historical and cultural city. Its rich history attracts many tourists; all the attendees will have the opportunity to enjoy the historic culture. Its rich history attracts many tourists; all the attendees will have the opportunity to enjoy the historic culture.

ICB-2018 & ICA-2018 & WCV-2018 will once again bring together thought leaders from pharmaceutical, biotech companies, consultants, regulatory authorities and academics, including well-known industry experts innovative technology developers and expert scientists, to present the latest research results, ideas, developments, applications and business prospects in Biotherapy, Antibody and Vaccines.

We cordially invite you to join us for this forward-thinking event in Washington D. C.. This conference will include plenary sessions, panel discussions, and paper presentations. Roundtable discussions, matchmaking, exhibitions, field trip and tech-tour will also help foster a fruitful exchange of information and ideas. 

We look forward to seeing you in Washington D. C. in 2018 for this influential event!